Developer docs
API playgroundTry for free, no card

Search company profiles

MS CENTER OF GREATER WASHINGTON PC

Full company profile

uuid004amzt

Namestring
MS CENTER OF GREATER WASHINGTON PC
Legal namestring
MS Center of Greater Washington, P.C.
Websiteurl
drcrayton.com
Company typeenum
Private
Founded yearint
2007
Descriptiontext

MS Center of Greater Washington PC is a private neurology practice (professional corporation) headquartered in Vienna, Virginia, that operates exclusively as a Multiple Sclerosis specialty center. Founded in 2007 by Dr. Heidi Crayton, the practice is described as the only full-time, non-academic MS center in the Mid-Atlantic region, with a clinical model organized around lifelong disease management rather than episodic general neurology care.

The practice is staffed by three board-certified MS neurologists — Dr. Heidi Crayton (founder and medical director), Dr. Nancy Hu, and Dr. Zachariah Hasan — supported by ten staff members. Clinical operations combine office-based neurology consultations, MRI-driven disease surveillance, and a high-volume on-site infusion suite that administers disease-modifying biologic therapies (e.g., Ocrevus, Tysabri) to 300+ infusion patients per month. The practice also serves as an active Principal Investigator site for sponsored MS clinical trials, integrating research revenue and early drug access into the standard care pathway.

Revenue is generated through fee-for-service neurology visits, infusion-administration billing (drug acquisition and/or facility fees under buy-and-bill or specialty-pharmacy models), and per-patient clinical trial budgets from biopharma sponsors. The customer base is the regional MS patient population across the Washington DC–Virginia–Maryland corridor, acquired primarily via word-of-mouth, regional neurology referrals, and the practice's own social media presence. The practice competes against academic MS programs at regional medical centers and large general neurology groups, with differentiation anchored in subspecialty depth, PI activity, and on-site infusion capability.

Short descriptiontext

MS Center of Greater Washington PC is a Vienna, Virginia neurology practice specializing exclusively in Multiple Sclerosis, founded in 2007 by Dr. Heidi Crayton. Three board-certified MS neurologists deliver chronic disease management, on-site biologic infusion therapy, and sponsored clinical trial research to Mid-Atlantic MS patients.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersVienna, United States
HQ citystring
Vienna
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
multiple sclerosis care, neurology services, clinical trials, infusion therapy, neurological treatment
Industry2 codes
1Neurodiagnostic Centers (EEG/EMG/NCS)
CodeHLAFAKAKPrimaryYes
2Neurorehabilitation Centers
CodeHLAFAFAHPrimaryNo
NAICS code1 code
  • Offices of Physicians (except Mental Health Specialists)621111
SIC code2 codes
  • Services-Offices & Clinics Of Doctors Of Medicine8011
  • Services-Specialty Outpatient Facilities, Nec8093
Product category
Neurology / Multiple Sclerosis Care
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Clinical Services Revenue
TypeSubscription Recurring
Description

Revenue from patient consultations, MS diagnosis, treatment planning, and ongoing neurological care services provided by board-certified neurologists.

drcrayton.com
2Infusion Services
TypeProfessional Services
Description

On-site infusion suite providing medication administration services. Serves 300+ patients per month with medications including Ocrevus, Tysabri, Briumvi, Lemtrada, and other MS therapies. Coordinates with manufacturer patient assistance programs for eligible patients.

drcrayton.com
3Clinical Trial Research
TypeProfessional Services
Description

The practice conducts clinical trials as a principal investigator site, providing patients access to experimental treatments while generating research revenue.

drcrayton.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

MS Center of Greater Washington PC is a private neurology practice that diagnoses and treats Multiple Sclerosis for adult patients in the Greater Washington, D.C. area. Its core services include MS consultations and ongoing disease management, on-site infusion therapy for MS disease-modifying drugs (serving 300+ patients per month), participation in MS clinical trials, medication financial assistance, and patient education through the healow patient portal.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Serves 300+ patients per month through on-site infusion suite
Product overview1 text field

MS Center of Greater Washington PC is a specialized neurology practice offering a unified suite of MS care services. The core offerings include MS Diagnosis & Treatment with personalized care plans, Clinical Trials for research access, and On-Site Infusion Services for medication administration (300+ patients monthly). Supporting services include a Patient Portal (healow) for online health management, Medication Financial Assistance programs connecting patients to manufacturer copay support, and MS Resources & Education. The practice operates as the only full-time non-academic MS center in the Mid-Atlantic, staffed by three board-certified neurologists with over 20 years of experience.

Product and service6 records
1MS Diagnosis and Treatment
CategoryNeurology Services
Description

Comprehensive medical evaluation and ongoing disease management for adults with Multiple Sclerosis, including consultative neurology visits, diagnostic workup, and treatment planning. Patients are typically referred by primary care physicians or general neurologists.

2On-Site Infusion Therapy
CategoryInfusion Services
Description

Infusion of MS disease-modifying therapies administered at the practice's Vienna, Virginia office, serving 300+ MS patients per month and eliminating the need for hospital-based infusion visits.

3Clinical Trial Participation
CategoryClinical Research Services
Description

Enrollment of eligible MS patients into Multiple Sclerosis clinical trials coordinated through the practice, giving patients access to investigational therapies not widely available.

4Medication Financial Assistance
CategoryPatient Support Services
Description

Coordination of patient financial assistance programs to help MS patients afford high-cost disease-modifying therapies.

5Patient Portal (healow)
CategoryPatient Engagement Technology
Description

healow-based patient portal used for communication with the care team, access to medical records, and patient engagement between office visits.

6MS Resources and Education
CategoryPatient Education
Description

Educational materials and resources provided to MS patients to support understanding of disease, treatment options, and self-management.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeOthers
Description

Provider of the healow patient portal platform used by MSCGW. Functions as a technology and patient-engagement infrastructure vendor rather than a clinical peer, but is materially relevant to the practice's day-to-day operations.

TypeBroad incumbent
Description

Manufacturer of Tysabri, one of the key MS biologics administered in MSCGW's infusion suite. While not a direct care provider, Biogen is a critical partner in the MS treatment ecosystem and a benchmark for the pharmaceutical side of the value chain.

TypeBroad incumbent
Description

A major pharmaceutical company that manufactures MS therapies (e.g., Kesimpta, Gilenya) directly relevant to the infusion and prescription services that MSCGW provides. As a manufacturer partner, it is a counterparty in the MS drug ecosystem the practice operates in.

TypeBroad incumbent
Description

An academic medical center MS program providing specialized MS care and clinical trials. Competes with MSCGW for complex MS patients in the broader Mid-Atlantic region and represents the academic alternative to MSCGW's non-academic model.

TypeRegional player
Description

A specialty rehabilitation and MS care provider in Atlanta, comparable to MSCGW's integrated care model but serving the Southeast U.S. rather than the Mid-Atlantic.

TypeBroad incumbent
Description

Academic neurology department where all three MSCGW neurologists trained. Provides a competing MS specialty practice and clinical trial site within the Washington, DC metro area, and is a natural source of referrals and talent.

7MS Center of Atlanta
TypeDirect peer
Description

A specialized non-academic MS center in the Southeast, comparable to MSCGW in offering dedicated MS diagnosis, treatment, infusion, and clinical trial services within a single practice. Operates a similar specialist-only model in a different geography.

TypeOthers
Description

A nonprofit patient advocacy and resource organization serving the MS community. Not a direct care provider but an ecosystem partner that influences patient referrals, education, and financial assistance pathways that MSCGW navigates for its patients.

TypeDirect peer
Description

A specialty MS clinic that provides comprehensive MS care, infusions, and clinical trials. Models the same multi-neurologist, full-time MS-focused practice concept as MSCGW, though based in the Mountain West region.

10Mellen Center for Multiple Sclerosis (Cleveland Clinic)
TypeBroad incumbent
Description

A leading academic MS center offering comprehensive MS diagnosis, treatment, infusion, and clinical trials. Operates within a large health system and represents the integrated academic specialty model against which MSCGW competes for complex referrals.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

MS CENTER OF GREATER WASHINGTON PC

Neurology / Multiple Sclerosis Caredrcrayton.com

MS Center of Greater Washington PC is a Vienna, Virginia neurology practice specializing exclusively in Multiple Sclerosis, founded in 2007 by Dr. Heidi Crayton. Three board-certified MS neurologists deliver chronic disease management, on-site biologic infusion therapy, and sponsored clinical trial research to Mid-Atlantic MS patients.

What MS CENTER OF GREATER WASHINGTON PC does

MS Center of Greater Washington PC is a private neurology practice (professional corporation) headquartered in Vienna, Virginia, that operates exclusively as a Multiple Sclerosis specialty center. Founded in 2007 by Dr. Heidi Crayton, the practice is described as the only full-time, non-academic MS center in the Mid-Atlantic region, with a clinical model organized around lifelong disease management rather than episodic general neurology care.

The practice is staffed by three board-certified MS neurologists — Dr. Heidi Crayton (founder and medical director), Dr. Nancy Hu, and Dr. Zachariah Hasan — supported by ten staff members. Clinical operations combine office-based neurology consultations, MRI-driven disease surveillance, and a high-volume on-site infusion suite that administers disease-modifying biologic therapies (e.g., Ocrevus, Tysabri) to 300+ infusion patients per month. The practice also serves as an active Principal Investigator site for sponsored MS clinical trials, integrating research revenue and early drug access into the standard care pathway.

Revenue is generated through fee-for-service neurology visits, infusion-administration billing (drug acquisition and/or facility fees under buy-and-bill or specialty-pharmacy models), and per-patient clinical trial budgets from biopharma sponsors. The customer base is the regional MS patient population across the Washington DC–Virginia–Maryland corridor, acquired primarily via word-of-mouth, regional neurology referrals, and the practice's own social media presence. The practice competes against academic MS programs at regional medical centers and large general neurology groups, with differentiation anchored in subspecialty depth, PI activity, and on-site infusion capability.

MS CENTER OF GREATER WASHINGTON PC firmographics

Firmographics
Name
MS CENTER OF GREATER WASHINGTON PC
Legal name
MS Center of Greater Washington, P.C.
Website
https://drcrayton.com
Company type
Private
Founded year
2007
Operating status
Operating
Headcount range
1–10 employees
Short description
MS Center of Greater Washington PC is a Vienna, Virginia neurology practice specializing exclusively in Multiple Sclerosis, founded in 2007 by Dr. Heidi Crayton. Three board-certified MS neurologists deliver chronic disease management, on-site biologic infusion therapy, and sponsored clinical trial research to Mid-Atlantic MS patients.
Ownership category
akta.pro rank

MS CENTER OF GREATER WASHINGTON PC industry classification

Industry
Product category
Neurology / Multiple Sclerosis Care
NAICS
Offices of Physicians (except Mental Health Specialists) (621111)
SIC
Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)
akta.pro primary industry
Neurodiagnostic Centers (EEG/EMG/NCS) (HLAFAKAK)
akta.pro secondary industry
Neurorehabilitation Centers (HLAFAFAH)

Keywords

  • Multiple sclerosis care
  • Neurology services
  • Clinical trials
  • Infusion therapy
  • Neurological treatment

Where MS CENTER OF GREATER WASHINGTON PC is headquartered

Location

Headquarters

HQ city
Vienna
HQ country
United States
HQ region
North America

Offices1 record

Markets served

MS CENTER OF GREATER WASHINGTON PC business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Clinical Services Revenue: Revenue from patient consultations, MS diagnosis, treatment planning, and ongoing neurological care services provided by board-certified neurologists.
  2. Infusion Services: On-site infusion suite providing medication administration services. Serves 300+ patients per month with medications including Ocrevus, Tysabri, Briumvi, Lemtrada, and other MS therapies. Coordinates with manufacturer patient assistance programs for eligible patients.
  3. Clinical Trial Research: The practice conducts clinical trials as a principal investigator site, providing patients access to experimental treatments while generating research revenue.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

MS CENTER OF GREATER WASHINGTON PC product offering

Product offering

Core offering

MS Center of Greater Washington PC is a private neurology practice that diagnoses and treats Multiple Sclerosis for adult patients in the Greater Washington, D.C. area. Its core services include MS consultations and ongoing disease management, on-site infusion therapy for MS disease-modifying drugs (serving 300+ patients per month), participation in MS clinical trials, medication financial assistance, and patient education through the healow patient portal.

Product overview

MS Center of Greater Washington PC is a specialized neurology practice offering a unified suite of MS care services. The core offerings include MS Diagnosis & Treatment with personalized care plans, Clinical Trials for research access, and On-Site Infusion Services for medication administration (300+ patients monthly). Supporting services include a Patient Portal (healow) for online health management, Medication Financial Assistance programs connecting patients to manufacturer copay support, and MS Resources & Education. The practice operates as the only full-time non-academic MS center in the Mid-Atlantic, staffed by three board-certified neurologists with over 20 years of experience.

Differentiator

Problem solved

Functional benefit

Products and services

  • MS Diagnosis and Treatment Comprehensive medical evaluation and ongoing disease management for adults with Multiple Sclerosis, including consultative neurology visits, diagnostic workup, and treatment planning. Patients are typically referred by primary care physicians or general neurologists.
  • On-Site Infusion Therapy Infusion of MS disease-modifying therapies administered at the practice's Vienna, Virginia office, serving 300+ MS patients per month and eliminating the need for hospital-based infusion visits.
  • Clinical Trial Participation Enrollment of eligible MS patients into Multiple Sclerosis clinical trials coordinated through the practice, giving patients access to investigational therapies not widely available.
  • Medication Financial Assistance Coordination of patient financial assistance programs to help MS patients afford high-cost disease-modifying therapies.
  • Patient Portal (healow) healow-based patient portal used for communication with the care team, access to medical records, and patient engagement between office visits.
  • MS Resources and Education Educational materials and resources provided to MS patients to support understanding of disease, treatment options, and self-management.

Quantifiable outcome

  • Serves 300+ patients per month through on-site infusion suite

Companies that use MS CENTER OF GREATER WASHINGTON PC

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles1 record

MS CENTER OF GREATER WASHINGTON PC technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

MS CENTER OF GREATER WASHINGTON PC partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

MS CENTER OF GREATER WASHINGTON PC competitors and assessment

Company assessment

Others

  • eClinicalWorks: Provider of the healow patient portal platform used by MSCGW. Functions as a technology and patient-engagement infrastructure vendor rather than a clinical peer, but is materially relevant to the practice's day-to-day operations.
  • Multiple Sclerosis Association of America (MSAA): A nonprofit patient advocacy and resource organization serving the MS community. Not a direct care provider but an ecosystem partner that influences patient referrals, education, and financial assistance pathways that MSCGW navigates for its patients.

Broad incumbents

  • Biogen: Manufacturer of Tysabri, one of the key MS biologics administered in MSCGW's infusion suite. While not a direct care provider, Biogen is a critical partner in the MS treatment ecosystem and a benchmark for the pharmaceutical side of the value chain.
  • Novartis Neurology (incl. Multiple Sclerosis franchise): A major pharmaceutical company that manufactures MS therapies (e.g., Kesimpta, Gilenya) directly relevant to the infusion and prescription services that MSCGW provides. As a manufacturer partner, it is a counterparty in the MS drug ecosystem the practice operates in.
  • Johns Hopkins MS Center: An academic medical center MS program providing specialized MS care and clinical trials. Competes with MSCGW for complex MS patients in the broader Mid-Atlantic region and represents the academic alternative to MSCGW's non-academic model.
  • Georgetown University Hospital Neurology: Academic neurology department where all three MSCGW neurologists trained. Provides a competing MS specialty practice and clinical trial site within the Washington, DC metro area, and is a natural source of referrals and talent.
  • Mellen Center for Multiple Sclerosis (Cleveland Clinic): A leading academic MS center offering comprehensive MS diagnosis, treatment, infusion, and clinical trials. Operates within a large health system and represents the integrated academic specialty model against which MSCGW competes for complex referrals.

Regional players

  • Shepherd Center (MS Program): A specialty rehabilitation and MS care provider in Atlanta, comparable to MSCGW's integrated care model but serving the Southeast U.S. rather than the Mid-Atlantic.

Direct peers

  • MS Center of Atlanta: A specialized non-academic MS center in the Southeast, comparable to MSCGW in offering dedicated MS diagnosis, treatment, infusion, and clinical trial services within a single practice. Operates a similar specialist-only model in a different geography.
  • Rocky Mountain MS Clinic: A specialty MS clinic that provides comprehensive MS care, infusions, and clinical trials. Models the same multi-neurologist, full-time MS-focused practice concept as MSCGW, though based in the Mountain West region.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

MS CENTER OF GREATER WASHINGTON PC social profiles

Digital presence

MS CENTER OF GREATER WASHINGTON PC financial estimates

Financial estimate

Revenue estimate

Valuation estimate

MS CENTER OF GREATER WASHINGTON PC leadership team

Management profile

Number of profiles

Profiles1 record

MS CENTER OF GREATER WASHINGTON PC funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

MS CENTER OF GREATER WASHINGTON PC M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MS CENTER OF GREATER WASHINGTON PC

What does MS CENTER OF GREATER WASHINGTON PC do?

MS Center of Greater Washington PC is a private neurology practice that diagnoses and treats Multiple Sclerosis for adult patients in the Greater Washington, D.C. area. Its core services include MS consultations and ongoing disease management, on-site infusion therapy for MS disease-modifying drugs (serving 300+ patients per month), participation in MS clinical trials, medication financial assistance, and patient education through the healow patient portal.

Is MS CENTER OF GREATER WASHINGTON PC a public or private company?

MS CENTER OF GREATER WASHINGTON PC is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was MS CENTER OF GREATER WASHINGTON PC founded?

MS CENTER OF GREATER WASHINGTON PC was founded in 2007. It employs 1 to 10 people.

Where is MS CENTER OF GREATER WASHINGTON PC based?

MS CENTER OF GREATER WASHINGTON PC is headquartered in Vienna, United States, in the North America region.

How does MS CENTER OF GREATER WASHINGTON PC make money?

Three revenue lines are on record. Clinical Services Revenue is the primary driver. The others are infusion Services and clinical Trial Research.

Who are MS CENTER OF GREATER WASHINGTON PC's main competitors?

Others on record are eClinicalWorks and Multiple Sclerosis Association of America (MSAA). Broad incumbents are Biogen, Novartis Neurology (incl. Multiple Sclerosis franchise), Johns Hopkins MS Center, Georgetown University Hospital Neurology and Mellen Center for Multiple Sclerosis (Cleveland Clinic). Shepherd Center (MS Program) is listed as a regional player. Direct peers are MS Center of Atlanta and Rocky Mountain MS Clinic.

Does MS CENTER OF GREATER WASHINGTON PC have an API?

No public API is recorded for MS CENTER OF GREATER WASHINGTON PC.

What industry is MS CENTER OF GREATER WASHINGTON PC in?

MS CENTER OF GREATER WASHINGTON PC's product category is Neurology / Multiple Sclerosis Care. Its primary akta.pro industry code is HLAFAKAK, Neurodiagnostic Centers (EEG/EMG/NCS), with a secondary code of HLAFAFAH, Neurorehabilitation Centers. Its NAICS code is 621111 and its SIC code is 8011.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales